Skip to main content

Point72 Asset Management, L.P.

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1603466 STAMFORD, CT

Position in MDGL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$73,577,721
-$44,469,998 QoQ
Shares Held
137,029
-39.2% QoQ
Ownership
0.593%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#35
of 411 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in MDGL Over Time

Shares Held

Position Value (USD)

Derivatives in MDGL

reported options exposure · as of Jun 30, 2026
CallValue
$1,825,630
CallShares
3,400
PutValue
$1,181,290
PutShares
2,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,264,515 across 171 Biotechnology names. MDGL ranks #6 (3.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 MDGL
Madrigal Pharmaceuticals, Inc.
This page
137,029 $73,577,721

All Filings in MDGL

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,825,630 3,400
2026-06-30 $1,181,290 2,200
2026-06-30 $73,577,721 137,029
2026-03-31 $2,565,003 4,900
2026-03-31 $2,355,615 4,500
2026-03-31 $118,047,719 225,510
2025-12-31 $73,628,157 126,435
2025-12-31 $2,911,700 5,000
2025-12-31 $3,086,402 5,300
2025-09-30 $18,911,927 41,233
2025-06-30 $33,555,815 110,877
2025-03-31 $21,814,807 65,860
2024-06-30 $11,474,793 40,958
2024-03-31 $40,056,000 150,000
2024-03-31 $24,987,199 93,571
2023-09-30 $25,250,316 172,900
2023-03-31 $967,344 3,993
2022-09-30 $1,486,711 22,876
2021-09-30 $2,401,679 30,100
2020-03-31 $5,267,364 78,900